Skip to main content

Security report for desitin.cz

Desitin Pharma spol. s r.o. · Healthcare · Czech Republic

Medium risk. 3 critical or high findings in SSL/TLS, GDPR outside view and 1 other check.

Security score

56/100

Risk levelMedium

0–100, higher is better. How it is calculated

Desitin Pharma spol. s r.o. is a Czech-based pharmaceutical company established in 1992 as a subsidiary of the German firm Desitin Arzneimittel GmbH. The company specializes in pharmaceutical products and nutritional supplements targeting central nervous system disorders and other health conditions. Their website serves both patients and healthcare professionals, providing product information, patient resources, and professional content. The company maintains a consistent brand presence and offers multilingual support through related country-specific domains. Technically, the website is built on WordPress with modern plugins for SEO and cookie management, ensuring a good user experience and compliance with privacy regulations. Security posture is solid with HTTPS and security headers, though no explicit security policy or incident response information is published. The absence of WHOIS data for the domain reduces trust in domain registration legitimacy, but the website content and business information appear professional and credible overall.

Scanned

NIS2 and GDPR posture

GDPR outside view
85/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      Unable to retrieve SSL certificate

      Could not establish secure connection to retrieve certificate information

      What to do: Check if the server is accessible and SSL/TLS is properly configured

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • High

      High-Risk Service Exposed: FTP

      Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

      What to do: Consider restricting access to FTP or implementing strong authentication

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

Need hands-on remediation? Email guard@offseq.com

Keep watching desitin.cz

This scan found 16 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
80
Email security
70
DNS health
80
Network security
20
GDPR outside view
85
Average
56

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company holds a stable position in the regional pharmaceutical market, leveraging its German parent company's heritage and expertise. Its business model focuses on manufacturing and distributing pharmaceutical and nutritional products, with a clear target audience of patients and healthcare professionals. The website links to product-specific partner sites, indicating a structured product ecosystem. The presence of privacy and cookie policies aligned with GDPR demonstrates regulatory compliance. The company appears medium-sized with a focused healthcare sector presence. Growth potential is supported by multilingual outreach and digital presence. However, the lack of visible WHOIS data and security policy documentation suggests areas for operational transparency improvement.

Security posture

The website enforces HTTPS and includes standard security headers, reflecting a good baseline security posture. Cookie consent is managed via a reputable plugin, ensuring GDPR compliance. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of a published security policy or incident response contact reduces transparency and preparedness perception. No vulnerability disclosure or security.txt file was found. Overall, the security maturity is moderate to good but could be enhanced by publishing formal security and incident response documentation and conducting regular security audits.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Provide clear incident response contact information to improve transparency and readiness.
  3. Regularly review and update third-party scripts and plugins to mitigate vulnerabilities.
  4. Enhance website accessibility features to improve compliance and user experience.
  5. Consider implementing a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Desitin Pharma spol. s r.o.
Description
DESITIN PHARMA, spol. s r.o. byla založena v Praze v roce 1992 jako dceřiná společnost německé farmaceutické firmy Desitin Arzneimittel GmbH.
Key services
pharmaceutical products, nutritional supplements, patient information, professional healthcare resources
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, Borlabs Cookie plugin, jQuery, Bootstrap, Google Maps API
Frameworks
Bootstrap
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent implemented
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics 4
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Google Analytics 4
Marketing tools
Yoast SEO
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a professional pharmaceutical company site with multilingual support.
  2. Content is primarily in Czech with links to other country-specific domains.
  3. Uses WordPress CMS with common plugins for SEO and cookie management.
  4. No WHOIS data available, which is unusual and reduces domain trust.
  5. Cookie consent and privacy policies are implemented and GDPR compliant.
  6. No explicit security policy or incident response information published.
  7. No suspicious or malicious content detected.
  8. Contact information includes a Czech phone number and contact form.
  9. External links mostly to related pharmaceutical product sites and social media.
Technical notes

Notes

The website is built on WordPress CMS using Bootstrap framework and common plugins such as Yoast SEO and Borlabs Cookie for SEO and privacy management. It integrates Google Maps API and uses jQuery and Bootstrap JavaScript libraries. The site is moderately performant with good mobile optimization and basic accessibility features. SEO is well implemented with meta tags, Open Graph, and JSON-LD structured data. Hosting provider details are not evident from the content. The technical stack is modern and standard for corporate websites but could benefit from enhanced accessibility and performance optimizations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with desitin.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review desitin.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.